Rehan Samirkhan Attar
Rehan Samirkhan Attar has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Arvind Mukundan
Department of Mechanical Engineering, National Chung Cheng University, Min Hsiung, Taiwan
1 shared publication - Honda Hsu
School of Medicine, Tzu Chi University, Hualien, Taiwan; Division of Plastic Surgery, Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Dalin, Taiwan
1 shared publication - Hsiang-Chen Wang
Department of Mechanical Engineering, National Chung Cheng University, Min Hsiung, Taiwan
1 shared publication - Kun-Hua Lee
Department of Trauma, Changhua Christian Hospital, No. 135, Nanxiao St., Changhua City 50006, Taiwan
1 shared publication - Ping-Hung Liu
Division of General Surgery, Kaohsiung Armed Forces General Hospital, 2, Zhongzheng 1st. Rd., Lingya District, Kaohsiung City 80284, Taiwan
1 shared publication - Riya Karmakar
Department of Mechanical Engineering, National Chung Cheng University, 168, University Rd., Min Hsiung, Chia-Yi 62102, Taiwan
1 shared publication
Latest Publications
- Top Cited PapersOpen Access
- 27 October 2025
- Published by MDPI AG in Diagnostics
- Vol. 15 (21) , 2718
From Innovation to Application: Can Emerging Imaging Techniques Transform Breast Cancer Diagnosis?
Background/Objectives: Breast cancer (BC) has emerged as a significant threat among female malignancies, resulting in approximately 670,000 fatalities. The capacity to identify BC has advanced over the past two decades because of deep learning (DL), machine learning (ML), and artificial intelligence. The early detection of BC is crucial; yet, conventional diagnostic techniques, including MRI, mammography, and biopsy, are costly, time-intensive, less sensitive, incorrect, and necessitate skilled physicians. This narrative review will examine six novel imaging approaches for BC diagnosis. Methods: Optical coherence tomography (OCT) surpasses existing approaches by providing non-invasive, high-resolution imaging. Raman Spectroscopy (RS) offers detailed chemical and structural insights into cancer tissue that traditional approaches cannot provide. Photoacoustic Imaging (PAI) provides superior optical contrast, exceptional ultrasonic resolution, and profound penetration and visualization capabilities. Hyperspectral Imaging (HSI) acquires spatial and spectral data, facilitating non-invasive tissue classification with superior accuracy compared to grayscale imaging. Contrast-Enhanced Spectral Mammography (CESM) utilizes contrast agents and dual energy to improve the visualization of blood vessels, enhance patient comfort, and surpass standard mammography in sensitivity. Multispectral Imaging (MSI) enhances tissue classification by employing many wavelength bands, resulting in high-dimensional images that surpass the ultrasound approach. The imaging techniques studied in this study are very useful for diagnosing tumors, staging them, and guiding surgery. They are not detrimental to morphological or immunohistochemical analysis, which is the gold standard for diagnosing breast cancer and determining molecular characteristics. Results: These imaging modalities provide enhanced sensitivity, specificity, and diagnostic accuracy. Notwithstanding their considerable potential, the majority of these procedures are not employed in standard clinical practices. Conclusions: Validations, standardization, and large-scale clinical trials are essential for the real-time application of these approaches. The analyzed studies demonstrated that the novel modalities displayed enhanced diagnostic efficacy, with reported sensitivities and specificities often exceeding those of traditional imaging methods. The results indicate that they may assist in early detection and surgical decision-making; however, for widespread adoption, they must be standardized, cost-reduced, and subjected to extensive clinical trials. This study offers a concise summary of each methodology, encompassing the methods and findings, while also addressing the many limits encountered in the imaging techniques and proposing solutions to mitigate these issues for future applications.
- 27 October 2025
- Published by MDPI AG in Diagnostics
- Vol. 15 (21) , 2718
Top Cited PapersOpen AccessFrom Innovation to Application: Can Emerging Imaging Techniques Transform Breast Cancer Diagnosis?
Background/Objectives: Breast cancer (BC) has emerged as a significant threat among female malignancies, resulting in approximately 670,000 fatalities. The capacity to identify BC has advanced over the past two decades because of deep learning (DL), machine learning (ML), and artificial intelligence. The early detection of BC is crucial; yet, conventional diagnostic techniques, including MRI, mammography, and biopsy, are costly, time-intensive, less sensitive, incorrect, and necessitate skilled physicians. This narrative review will examine six novel imaging approaches for BC diagnosis. Methods: Optical coherence tomography (OCT) surpasses existing approaches by providing non-invasive, high-resolution imaging. Raman Spectroscopy (RS) offers detailed chemical and structural insights into cancer tissue that traditional approaches cannot provide. Photoacoustic Imaging (PAI) provides superior optical contrast, exceptional ultrasonic resolution, and profound penetration and visualization capabilities. Hyperspectral Imaging (HSI) acquires spatial and spectral data, facilitating non-invasive tissue classification with superior accuracy compared to grayscale imaging. Contrast-Enhanced Spectral Mammography (CESM) utilizes contrast agents and dual energy to improve the visualization of blood vessels, enhance patient comfort, and surpass standard mammography in sensitivity. Multispectral Imaging (MSI) enhances tissue classification by employing many wavelength bands, resulting in high-dimensional images that surpass the ultrasound approach. The imaging techniques studied in this study are very useful for diagnosing tumors, staging them, and guiding surgery. They are not detrimental to morphological or immunohistochemical analysis, which is the gold standard for diagnosing breast cancer and determining molecular characteristics. Results: These imaging modalities provide enhanced sensitivity, specificity, and diagnostic accuracy. Notwithstanding their considerable potential, the majority of these procedures are not employed in standard clinical practices. Conclusions: Validations, standardization, and large-scale clinical trials are essential for the real-time application of these approaches. The analyzed studies demonstrated that the novel modalities displayed enhanced diagnostic efficacy, with reported sensitivities and specificities often exceeding those of traditional imaging methods. The results indicate that they may assist in early detection and surgical decision-making; however, for widespread adoption, they must be standardized, cost-reduced, and subjected to extensive clinical trials. This study offers a concise summary of each methodology, encompassing the methods and findings, while also addressing the many limits encountered in the imaging techniques and proposing solutions to mitigate these issues for future applications.